Tatsuya Sakane

1PUBLICATIONS
4CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 18, 2025
Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis.

Tatsuya Sakane, Toshifumi Tada, Hiroshi Tei

Pageof 1